StockrabitBrowse analysts
Analyst questions

Viraj Mahadevia

MoneyGrow with his question now
SUDARSHAN

Sudarshan Pharma Industries Ltd

All company calls
Sudarshan Chemical Industries Limited
14 Aug 2026
Open call
  1. I am new to the Company but congratulations on an astute bit of deal making here with Heubach. Quick question, Sir. Before Heubach started its troubles a few years ago it used to be a billion euro topline business, Sudarshan more recently has done Rs.9000 Crores in topline, so the combination of the two do you see a more aggressive growth, revenue growth going forward as you can build effectively another Sudarshan…

    Read in transcript
  2. Yes, Sir I agree on the cost side and the synergies and China plus one coming from India, but on the revenue side itself even if Heubach was doing Rs.5000 Crores equivalent of revenue after the acquisition that leaves substantial growth to potentially to recapture some of that lost business is that on the agenda because you should be able to grow your market share faster than the overall market?

    Read in transcript